PIONEER TEENS Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes.
The PIONEER TEENS study is investigating a new oral medication, Rybelsus, for young people with type 2 diabetes. Researchers want to understand how well Rybelsus works to control blood sugar levels, especially when taken alongside other common diabetes treatments like metformin or insulin. They will also carefully check if the medicine is safe and if there are any side effects. To do this, some participants will receive Rybelsus, while others will get a placebo (a dummy pill that looks the same but has no medicine). The study will look at various health markers, like blood sugar levels, body weight, and blood pressure, over several months to see if Rybelsus makes a difference compared to placebo. It's a key step in finding better ways to manage type 2 diabetes in teenagers.
At a glance
What is this study about?
The PIONEER TEENS study is all about finding better ways to help young people living with type 2 diabetes. Type 2 diabetes means your body doesn't use insulin properly, leading to high blood sugar levels. This study is testing a medicine called Rybelsus, which is taken as a tablet, to see how it works in children and teenagers.
Researchers want to see if Rybelsus, when used with other common diabetes medicines like metformin or insulin, can effectively lower blood sugar levels. They will compare it to a 'placebo', which is a dummy tablet that looks just like the real medicine but contains no active ingredients. This helps them understand if any changes seen are truly due to Rybelsus or other factors. The study will also carefully monitor any side effects to make sure the medicine is safe.
The main thing they'll be looking at is a measurement called HbA1c, which gives an average of your blood sugar levels over the past few months. They will check this, along with other health markers like body weight, blood pressure, and how quickly sugar is absorbed by your body, over many weeks. The goal is to gather important information that could help doctors provide better care for young people with type 2 diabetes in the future.
Key takeaways
- This study is testing Rybelsus tablets for teenagers with type 2 diabetes.
- It aims to see how well Rybelsus helps control blood sugar when used with other diabetes medicines.
- Participants will receive either Rybelsus or a placebo (dummy pill).
- Doctors will closely monitor blood sugar, weight, and general health.
- The study also looks for any potential side effects of the medicine.
Who may be eligible?
To be able to take part in this study, you would need to be a child or teenager who has been diagnosed with type 2 diabetes.
The study is open to both boys and girls. Besides having type 2 diabetes, there might be other specific health requirements or conditions you need to meet, or not have, to ensure the study is safe and suitable for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do you have type 2 diabetes?
- Are you a child or a teenager?
- Are you currently taking metformin and/or basal insulin for your diabetes?
- Are you able to take a tablet medicine by mouth?
- Are you comfortable with attending regular clinic visits and having blood tests?
What does participation involve?
If you decide to take part in this study, you would be given either Rybelsus tablets or a placebo (a dummy tablet) to take. You would continue to take your existing diabetes medicines, such as metformin or insulin, alongside the study treatment. Throughout the study, you would attend regular visits with the study team. These visits would involve health checks, blood tests to measure your blood sugar levels and other important markers, and discussions about how you are feeling. The researchers would monitor your health and any changes very carefully. The study will last for a number of months, and you'll have follow-up appointments to check on your health even after you've stopped taking the study medicine.
Potential risks and benefits
Locations (6)
- —UnverifiedGreece
- —UnverifiedCzechia
- —UnverifiedPortugal
- —UnverifiedRomania
- —UnverifiedAustria
- —UnverifiedNetherlands
Common questions
What is Rybelsus?
Rybelsus is a tablet medicine being studied to help control blood sugar in people with type 2 diabetes.
What is a 'placebo'?
A placebo is a dummy tablet that looks like the real medicine but doesn't have any active ingredients. It helps researchers compare the effects of the actual medicine.
What is HbA1c?
HbA1c is a blood test that shows your average blood sugar levels over the past two to three months. It helps doctors see how well your diabetes is being managed.
Will I still take my regular diabetes medicine?
Yes, if you're taking metformin and/or insulin, you would continue to take them as prescribed alongside the study medicine (Rybelsus or placebo).
How long will the study last?
The study involves taking the medicine for 26 weeks, and then there will be further checks up to about 52 weeks in total to see how you are doing.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.